Leishmania is a microorganism threatening the health of over 500 million people at risk of crossing its path. Although leishmaniasis, the disease caused by the parasite, has been on the radar of scientists for a long time, the quest for affordable and effective treatment continues. Researchers have now developed a new, cost-effective strategy to rapidly identify molecules capable of eliminating Leishmania.